Guidelines for the management of diabetes services and patients during the COVID-19 pandemic

G. Rayman; A. Lumb; B. Kennon; C. Cottrell; D. Nagi; E. Page; D. Voigt; H. Courtney; H. Atkins; J. Platts; K. Higgins; K. Dhatariya; M. Patel; P. Narendran; P. Kar; P. Newland-Jones; R. Stewart; O. Burr; S. Thomas

doi:10.1111/dme.14316

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic

G. Rayman (Lead / Corresponding author), A. Lumb, B. Kennon, C. Cottrell, D. Nagi, E. Page, D. Voigt, H. Courtney, H. Atkins, J. Platts, K. Higgins, K. Dhatariya, M. Patel, P. Narendran, P. Kar, P. Newland-Jones, R. Stewart, O. Burr, S. Thomas,

Postgraduate Medicine

Research output: Contribution to journal › Article › peer-review

36 Citations (Scopus)

142 Downloads (Pure)

Abstract

The UK National Diabetes Inpatient COVID Response Group was formed at the end of March 2020 to support the provision of diabetes inpatient care during the COVID pandemic. It was formed in response to two emerging needs. First to ensure that basic diabetes services are secured and maintained at a time when there was a call for re-deployment to support the need for general medical expertise across secondary care services. The second was to provide simple safe diabetes guidelines for use by specialists and non-specialists treating inpatients with or suspected of COVID-19 infection. To date the group, comprising UK-based specialists in diabetes, pharmacy and psychology, have produced two sets of guidelines which will be continually revised as new evidence emerges. It is supported by Diabetes UK, the Association of British Clinical Diabetologists and NHS England.

Original language	English
Pages (from-to)	1087-1089
Number of pages	3
Journal	Diabetic Medicine
Volume	37
Issue number	7
Early online date	4 May 2020
DOIs	https://doi.org/10.1111/dme.14316
Publication status	Published - Jul 2020

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dme.14316

Author Accepted ManuscriptAccepted author manuscript, 581 KB

Cite this

Rayman, G., Lumb, A., Kennon, B., Cottrell, C., Nagi, D., Page, E., Voigt, D., Courtney, H., Atkins, H., Platts, J., Higgins, K., Dhatariya, K., Patel, M., Narendran, P., Kar, P., Newland-Jones, P., Stewart, R., Burr, O., Thomas, S. (2020). Guidelines for the management of diabetes services and patients during the COVID-19 pandemic. Diabetic Medicine, 37(7), 1087-1089. https://doi.org/10.1111/dme.14316

@article{7f46c28804474956a31c530b93bb347e,

title = "Guidelines for the management of diabetes services and patients during the COVID-19 pandemic",

abstract = "The UK National Diabetes Inpatient COVID Response Group was formed at the end of March 2020 to support the provision of diabetes inpatient care during the COVID pandemic. It was formed in response to two emerging needs. First to ensure that basic diabetes services are secured and maintained at a time when there was a call for re-deployment to support the need for general medical expertise across secondary care services. The second was to provide simple safe diabetes guidelines for use by specialists and non-specialists treating inpatients with or suspected of COVID-19 infection. To date the group, comprising UK-based specialists in diabetes, pharmacy and psychology, have produced two sets of guidelines which will be continually revised as new evidence emerges. It is supported by Diabetes UK, the Association of British Clinical Diabetologists and NHS England.",

author = "G. Rayman and A. Lumb and B. Kennon and C. Cottrell and D. Nagi and E. Page and D. Voigt and H. Courtney and H. Atkins and J. Platts and K. Higgins and K. Dhatariya and M. Patel and P. Narendran and P. Kar and P. Newland-Jones and R. Stewart and O. Burr and S. Thomas",

note = "{\textcopyright} 2020 Diabetes UK.",

year = "2020",

month = jul,

doi = "10.1111/dme.14316",

language = "English",

volume = "37",

pages = "1087--1089",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley",

number = "7",

}

Rayman, G, Lumb, A, Kennon, B, Cottrell, C, Nagi, D, Page, E, Voigt, D, Courtney, H, Atkins, H, Platts, J, Higgins, K, Dhatariya, K, Patel, M, Narendran, P, Kar, P, Newland-Jones, P, Stewart, R, Burr, O, Thomas, S 2020, 'Guidelines for the management of diabetes services and patients during the COVID-19 pandemic', Diabetic Medicine, vol. 37, no. 7, pp. 1087-1089. https://doi.org/10.1111/dme.14316

TY - JOUR

T1 - Guidelines for the management of diabetes services and patients during the COVID-19 pandemic

AU - Rayman, G.

AU - Lumb, A.

AU - Kennon, B.

AU - Cottrell, C.

AU - Nagi, D.

AU - Page, E.

AU - Voigt, D.

AU - Courtney, H.

AU - Atkins, H.

AU - Platts, J.

AU - Higgins, K.

AU - Dhatariya, K.

AU - Patel, M.

AU - Narendran, P.

AU - Kar, P.

AU - Newland-Jones, P.

AU - Stewart, R.

AU - Burr, O.

AU - Thomas, S.

PY - 2020/7

Y1 - 2020/7

N2 - The UK National Diabetes Inpatient COVID Response Group was formed at the end of March 2020 to support the provision of diabetes inpatient care during the COVID pandemic. It was formed in response to two emerging needs. First to ensure that basic diabetes services are secured and maintained at a time when there was a call for re-deployment to support the need for general medical expertise across secondary care services. The second was to provide simple safe diabetes guidelines for use by specialists and non-specialists treating inpatients with or suspected of COVID-19 infection. To date the group, comprising UK-based specialists in diabetes, pharmacy and psychology, have produced two sets of guidelines which will be continually revised as new evidence emerges. It is supported by Diabetes UK, the Association of British Clinical Diabetologists and NHS England.

AB - The UK National Diabetes Inpatient COVID Response Group was formed at the end of March 2020 to support the provision of diabetes inpatient care during the COVID pandemic. It was formed in response to two emerging needs. First to ensure that basic diabetes services are secured and maintained at a time when there was a call for re-deployment to support the need for general medical expertise across secondary care services. The second was to provide simple safe diabetes guidelines for use by specialists and non-specialists treating inpatients with or suspected of COVID-19 infection. To date the group, comprising UK-based specialists in diabetes, pharmacy and psychology, have produced two sets of guidelines which will be continually revised as new evidence emerges. It is supported by Diabetes UK, the Association of British Clinical Diabetologists and NHS England.

UR - http://www.scopus.com/inward/record.url?scp=85084512260&partnerID=8YFLogxK

U2 - 10.1111/dme.14316

DO - 10.1111/dme.14316

M3 - Article

C2 - 32365233

SN - 0742-3071

VL - 37

SP - 1087

EP - 1089

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 7

ER -

Guidelines for the management of diabetes services and patients during the COVID-19 pandemic

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this